Hot Investor Mandate: Investment Firm in Korea Seeks Therapeutics & Diagnostics Technologies in CNS, Oncology/Immuno-Oncology

6 Feb

A holding company based in South Korea is actively seeking global early-stage investment opportunities in bio/healthcare sectors, and actively invest in biotech VC funds as well. Initial size of investment largely depends on a deal-by-deal basis.

With regards to life sciences, the firm is most interested in therapeutics or diagnostics companies with a particular interest in platform technologies. The firm is most interested in CNS, oncology, and immuno-oncology opportunities. While the firm is open to investing in medical devices or digital health, these are not a priority for the firm.

The firm does not have specific company or management team requirements. The firm does not require companies to have a Korea angle or market potential in Korea, but the firm can provide strategic value add if the companies were interested in Asia market expansion.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: